MUMBAI: Ahead of the first-ever United Nations High level Meeting next month, the World Health Organisation on Friday announced crucial changes to the multi drug resistant TB treatment regimen, which includes expanding the usage of the latest tuberculosis drug, Bedaquiline. It also calls on countries to minimize the use of injectibles, which are known to cause serious side effects in patients.
Zhejiang Hisun Pharmaceutical, Co., Ltd. (Yantou Campus) Fails EDQM Inspection